{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-113978","form_type":"8-K","ticker":"PMN","cik":"0001374339","company_name":"ProMIS Neurosciences Inc.","filed_at":"2025-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.251588+00:00","generated_at":"2026-05-16T18:23:48.297046+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Shareholders approve reverse stock split authorization for ProMIS Neurosciences","bullets":["Special meeting on Nov 17, 2025; 24.3M of 53.8M shares voted (45% quorum).","Share Consolidation Proposal approved: 21,331,321 for, 2,939,187 against.","Board authorized to effect 1:5 to 1:25 reverse split within one year at its discretion.","Adjournment proposal also passed with 22.3M in favor.","No broker non-votes; action allows potential Nasdaq compliance maintenance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-113978","json":"https://secwatch.observer/filing/0001104659-25-113978.json","markdown":"https://secwatch.observer/filing/0001104659-25-113978.md","text":"https://secwatch.observer/filing/0001104659-25-113978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925113978/0001104659-25-113978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925113978/pmn-20251117x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:23:48.297046+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}